Houston-based ROGII has acquired a new software to integrate into its platform. Photo via ROGII.com

An advanced geosteering, geoscience, and drilling software solutions company based in Houston has announced the acquisition of of a software platform.

ROGII plans to acquire TerraSLS's TLog Mudlog Editor software, which is used to generate vertical, and horizontal striplogs for use by geologists. The acquisition “will significantly enhance ROGII's product offerings by providing operators and clients with unprecedented real-time connectivity to mudlogging data,” according to ROGII. Mudlogging is a process that involves examining the cuttings of rock brought to the surface by the drilling.

“Our acquisition of TLog marks another step forward in our mission to deliver the most advanced, real-time data solutions to the oil and gas industry,” CEO of ROGII Igor B. Uvarov says in a news release. “The integration of TLog’s capabilities into our Solo Cloud platform will revolutionize the way operators and mudlogging service companies interact, making mudlogging a truly real-time process and driving greater efficiency and collaboration.”

One way it works is that ROGII will integrate TLog into its Solo Cloud platform, which will advance mudlogging data. This gathers it all into a real-time data exchange between mudlogging service companies and its operators.

The integration will allow operators to monitor mudlogging activities in real-time, which means a possible faster and more informed decision-making processes. The user will get immediate access to data, which can help enhance collaboration and improve efficiency. In addition, the mudlogging data will be safely stored on Solo Cloud for future analysis and data integration, which assists with maintaining integrity of the data.

“We look forward to investing in further development of TLog, increasing user-friendliness, expanding adoption worldwide, and making it the industry standard, being used by all mudlogging service companies,” Uvarov adds.

------

This article originally ran on EnergyCapital.

The Karimi siblings have created a way to synthetically convert CO2 into glucose, and they are targeting the energy and aerospace industries for their technology. Courtesy of Cemvita Factory

Houston company is solving the energy and space industries' carbon dioxide problems with synthetic photosynthesis

See ya, CO2

Houston-based Cemvita Factory is unlike most startups. Before even knowing what industry they were going to affect, Moji Karimi and his sister, Tara, established their company, which uses synthetic photosynthesis — the process of turning carbon dioxide into glucose for plants.

"In some ways, this company started with the solution, rather than the problem," Moji Karimi, co-founder of Cemvita, says. "Then we said, 'if we could replicate photosynthesis, what problems can we solve?'"

Once the technology was set in place, Karimi, who has a background in oil and gas drilling, says he identified the energy industry in need of something like this. He says he saw an increased pressure on large energy companies to adapt sustainable ways to get rid of the CO2 that is produced as a result of drilling.

More and more companies are investing in a process called carbon dioxide capturing — but it's expensive and not yet cost efficient for energy companies to commit to. But that's changing. Karimi says the process that once cost $600 per ton of CO2 now can be found as cheap as $30.

With his sister's technology, Karimi says they can take that captured carbon dioxide and turn it into other chemicals too. Each oil and gas company client can specify what they want to turn it into and, for less than $100,000, Cemvita will run a pilot program for them. Cemvita sells the exclusive rights to the technology, but still maintains its IP.

"We go to these companies and say, 'What do you want to convert CO2 into?,'" Karimi says. "Then, we do a quick pilot in six months in our lab, and we show them the metrics. They decide if they want to scale it up."

What seemed like another obvious industry for this process was aerospace. Many companies involved in aerospace exploration have Mars on the mind, and the planet's atmosphere is over 95 percent carbon dioxide. Plus, Cemvita can provide a more sustainable way to dispose of CO2 onboard spacecrafts. The current practice is essentially just discarding it by filtering it off the spaceship.

Putting a system in place
Cemvita was founded in August of 2017 and used 2018 to really establish itself. The company took second place at Dubai's Mohammed bin Rashid Space Centre Innovation Challenge and completed the accelerator program at Capital Factory.

Realizing the process is new and without the backing of an educational institution, Karimi says he and his sister needed a way to answer any questions and concerns, so Tara wrote a book. "Molecular Mechanisms of Autonomy in Biological Systems" is published by Springer.

Karimi also lead a talk at Tudor Pickering Holt's Energy Disruptor conference. His discussion, "From Mars to Midland," garnered a lot of interest from energy professionals.

The future is now
Karimi says 2019 is all about execution. He never thought he and his sister would overlap their industries, but now there's more of a need of interdisciplinary collaboration than ever before.

"There are a lot of opportunities bringing a proven science or technology from one industry into another to solve problems," he says.

The company has growth plans this year. The team has bootstrapped everything financially so far, but is looking for its first funding round in the middle of 2019. And, as far as the Karimi siblings are concerned, they are in the exact right place to grow.

"We're in Houston, and we have a technology that is from biotech and have applications in the space industry and the energy industry," Karimi says. "There would not have been any better place for us in the country than Houston."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”